Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury

Official title: A Randomized, Double-Blind, Sham-Controlled Trial of Sacral Nerve Root High-Frequency Magnetic Stimulation Combined With Ultrasound Therapy for Detrusor Overactivity in Patients With Spinal Cord Injury

Run by Shengjing Hospital · NCT07704268 · Data updated 2026-11-12

This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment44 (estimated)
SponsorShengjing Hospital
Academic / other
Locations1 site (Shenyang)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07704268 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18-80 with SCI above the sacral level and documented detrusor overactivity who can comply with study visits and procedures.

Probably not a fit

Patients without detrusor overactivity or with unstable medical conditions or implants near the stimulation area may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial assesses whether combining two therapies—high-frequency sacral nerve root magnetic stimulation and bladder-directed ultrasound—provides added benefit over magnetic stimulation alone for detrusor overactivity in SCI. Participants are randomly assigned to receive magnetic stimulation, bladder ultrasound, or both, once daily for three weeks (seven sessions per week). Before and after treatment, urodynamic testing and bladder/urinary tract ultrasound assess safety and bladder health, along with voiding diaries and validated quality-of-life questionnaires. The study is conducted at the Rehabilitation Center of Shengjing Hospital in Shenyang, China, sponsored by Shengjing Hospital.

Why it matters

Potential benefit: If successful, the combined therapy could offer a more effective non-pharmacologic option to reduce detrusor overactivity and improve urinary function in SCI patients.

How similar studies have gone: Previous approaches using neuromodulation or ultrasound for bladder function have shown potential benefits, but the combined approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of spinal cord injury (SCI) above the sacral level according to the International Standards for Neurological Classification of Spinal Cord Injury (revised 2011), confirmed by CT or MRI;
2. Detrusor overactivity confirmed by urodynamic study;
3. No severe urinary system diseases such as tumors, stones, infection, or organic urinary tract obstruction;
4. No severe hepatic/renal insufficiency, pulmonary, or cardiovascular diseases;
5. Aged 18-80 years;
6. Able to understand and comply with the required examinations, rehabilitation assessments, and treatment, and provide written informed consent.

Exclusion Criteria:

1. Unstable vital signs or critically ill condition;
2. Severe autonomic dysreflexia;
3. Presence of metallic implants within 10 cm of the magnetic stimulation treatment area;
4. Any other diseases or conditions that may interfere with the study outcomes.

Where it's running

  • Rehabilitation Center of Shengjing Hospital, China Medical University, shenyang, Liaoning 110000
    Shenyang, China
    Recruiting

Study contacts

  • Principal investigator: Xue Jiang — Rehabilitation Center of Shengjing Hospital, China Medical University
  • Study coordinator: Xue Jiang
  • Email: jiangxueruby@163.com
  • Phone: +86 18940254064

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.